Ingelheim am Rhein

Feb 12, 2018

Boehringer Ingelheim Demonstrates their Commitment to Site Relationships by Joining SCRS' Global Impact Partner Program

Feb 05, 2018

Merial, Now Part of Boehringer Ingelheim, Grows Canine Vaccine Portfolio With Introduction of RECOMBITEK® Oral Bordetella

Dec 20, 2017

Knowledge Of Biosimilars: Survey Of 100+ U.S. Rheumatologists Shows Familiarity But Need For Further Education

Dec 11, 2017

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

Dec 04, 2017

Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S.

Nov 09, 2017

Diversity in clinical trials critical to refining medicines and therapies

Oct 19, 2017

Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research

Sep 25, 2017

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

Jul 25, 2017

The Maker of NexGard® (afoxolaner) and North Shore Animal League America are Celebrating the Dog Days of Summer on "DOGust the 1st" With a Mobile Pet Adoption Event

Jul 21, 2017

Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility

Jun 06, 2017

Novatek International Selected As Partner for Automation of Boehringer Ingelheim's Global Environmental Monitoring Program